NM_007357.3:c.1014T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_007357.3(COG2):​c.1014T>C​(p.Asp338Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00571 in 1,611,642 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0041 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 33 hom. )

Consequence

COG2
NM_007357.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.822

Publications

2 publications found
Variant links:
Genes affected
COG2 (HGNC:6546): (component of oligomeric golgi complex 2) This gene encodes a subunit of the conserved oligomeric Golgi complex that is required for maintaining normal structure and activity of the Golgi complex. The encoded protein specifically interacts with the USO1 vesicle docking protein and may be necessary for normal Golgi ribbon formation and trafficking of Golgi enzymes. Mutations of this gene are associated with abnormal glycosylation within the Golgi apparatus. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009]
COG2 Gene-Disease associations (from GenCC):
  • congenital disorder of glycosylation, type IIq
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 1-230675112-T-C is Benign according to our data. Variant chr1-230675112-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 478370.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.822 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00409 (623/152330) while in subpopulation NFE AF = 0.00683 (465/68036). AF 95% confidence interval is 0.00632. There are 3 homozygotes in GnomAd4. There are 275 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COG2NM_007357.3 linkc.1014T>C p.Asp338Asp synonymous_variant Exon 9 of 18 ENST00000366669.9 NP_031383.1 Q14746-1B1ALW7
COG2NM_001145036.2 linkc.1014T>C p.Asp338Asp synonymous_variant Exon 9 of 18 NP_001138508.1 Q14746-2
COG2XM_047449445.1 linkc.675T>C p.Asp225Asp synonymous_variant Exon 7 of 16 XP_047305401.1
LOC107985358XR_001738517.1 linkn.187A>G non_coding_transcript_exon_variant Exon 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COG2ENST00000366669.9 linkc.1014T>C p.Asp338Asp synonymous_variant Exon 9 of 18 1 NM_007357.3 ENSP00000355629.4 Q14746-1

Frequencies

GnomAD3 genomes
AF:
0.00409
AC:
623
AN:
152212
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00150
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00399
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00683
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00473
AC:
1178
AN:
248910
AF XY:
0.00496
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00262
Gnomad ASJ exome
AF:
0.000896
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00134
Gnomad NFE exome
AF:
0.00740
Gnomad OTH exome
AF:
0.00547
GnomAD4 exome
AF:
0.00588
AC:
8575
AN:
1459312
Hom.:
33
Cov.:
30
AF XY:
0.00587
AC XY:
4260
AN XY:
725812
show subpopulations
African (AFR)
AF:
0.00138
AC:
46
AN:
33414
American (AMR)
AF:
0.00300
AC:
133
AN:
44370
Ashkenazi Jewish (ASJ)
AF:
0.00103
AC:
27
AN:
26098
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39644
South Asian (SAS)
AF:
0.00517
AC:
442
AN:
85498
European-Finnish (FIN)
AF:
0.00165
AC:
88
AN:
53364
Middle Eastern (MID)
AF:
0.00555
AC:
32
AN:
5762
European-Non Finnish (NFE)
AF:
0.00677
AC:
7515
AN:
1110862
Other (OTH)
AF:
0.00483
AC:
291
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
396
793
1189
1586
1982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00409
AC:
623
AN:
152330
Hom.:
3
Cov.:
32
AF XY:
0.00369
AC XY:
275
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00149
AC:
62
AN:
41576
American (AMR)
AF:
0.00399
AC:
61
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4826
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00683
AC:
465
AN:
68036
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
29
58
87
116
145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00511
Hom.:
1
Bravo
AF:
0.00403
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.00670
EpiControl
AF:
0.00690

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COG2: BP4, BP7, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital disorder of glycosylation, type IIq Benign:1
Nov 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

COG2-related disorder Benign:1
Jul 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
3.1
DANN
Benign
0.25
PhyloP100
0.82
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113173809; hg19: chr1-230810858; COSMIC: COSV64187178; API